Mapping Cell-in-Cell Structures in Oral Squamous Cell Carcinoma.

Humans Squamous Cell Carcinoma of Head and Neck Carcinoma, Squamous Cell / pathology Mouth Neoplasms / pathology Reproducibility of Results Head and Neck Neoplasms Tumor Microenvironment
cancer-associated fibroblasts cell cannibalism cell-in-cell structures oral squamous cell carcinoma tumor spheroids

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
08 10 2023
Historique:
received: 27 07 2023
revised: 10 09 2023
accepted: 11 09 2023
medline: 23 10 2023
pubmed: 13 10 2023
entrez: 13 10 2023
Statut: epublish

Résumé

Cell-in-cell (CIC) structures contribute to tumor aggressiveness and poor prognosis in oral squamous cell carcinoma (OSCC). In vitro 3D models may contribute to the understanding of the underlying molecular mechanisms of these events. We employed a spheroid model to study the CIC structures in OSCC. Spheroids were obtained from OSCC (HSC3) and cancer-associated fibroblast (CAF) lines using the Nanoshuttle-PL

Identifiants

DOI: 10.3390/cells12192418 PMID: 37830632 PMC: PMC10572403
pubmed: 37830632
pii: cells12192418
doi: 10.3390/cells12192418
pmc: PMC10572403
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Vis Exp. 2017 Aug 23;(126):
pubmed: 28872142
Front Oncol. 2022 Jun 30;12:931092
pubmed: 35847959
Adv Healthc Mater. 2019 Feb;8(4):e1801363
pubmed: 30605261
Sci Rep. 2019 Dec 12;9(1):18916
pubmed: 31831785
J Cell Biol. 2019 Nov 4;218(11):3827-3844
pubmed: 31530580
Int J Mol Sci. 2022 Nov 19;23(22):
pubmed: 36430867
Sci Rep. 2021 Jan 12;11(1):584
pubmed: 33436723
PLoS One. 2015 Dec 15;10(12):e0145016
pubmed: 26671576
Cells. 2021 Nov 26;10(12):
pubmed: 34943822
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211036304
pubmed: 34350796
PLoS One. 2018 Dec 31;13(12):e0209094
pubmed: 30596678
Med Oral Patol Oral Cir Bucal. 2022 May 1;27(3):e274-e284
pubmed: 35368013
Methods Mol Biol. 2016;1406:239-51
pubmed: 26820961
Cell Biosci. 2022 Sep 11;12(1):155
pubmed: 36089610
Cells. 2021 Sep 28;10(10):
pubmed: 34685548
In Vitro Cell Dev Biol Anim. 2022 May;58(5):349-364
pubmed: 35536385
Biomed Res Int. 2015;2015:359392
pubmed: 26504802
Gulf J Oncolog. 2017 Jan;1(23):52-56
pubmed: 28272003
Nat Cancer. 2022 Jul;3(7):852-865
pubmed: 35681100
Biomaterials. 2018 Oct;179:71-82
pubmed: 29980076
Mol Oncol. 2021 May;15(5):1391-1411
pubmed: 33528867
BMB Rep. 2018 Aug;51(8):412-417
pubmed: 30021676
Oral Dis. 2021 Jul;27(5):1148-1160
pubmed: 32989819
Aging (Albany NY). 2016 Dec 15;9(1):114-132
pubmed: 27992856
Life Sci. 2022 Jan 1;288:120163
pubmed: 34822797
Biochim Biophys Acta. 2013 Dec;1832(12):2027-34
pubmed: 23871839
J Cell Sci. 2019 Jan 9;132(1):
pubmed: 30559248
Exp Cell Res. 1973 Dec;82(2):319-24
pubmed: 4128812
Front Cell Dev Biol. 2019 Dec 03;7:311
pubmed: 31850347
Br J Exp Pathol. 1968 Dec;49(6):541-3
pubmed: 5751062
J Cancer Res Ther. 2019 Jul-Sep;15(3):631-637
pubmed: 31169232
J Extracell Vesicles. 2019 Feb 13;8(1):1578525
pubmed: 30788085
Nat Rev Mol Cell Biol. 2008 Oct;9(10):796-809
pubmed: 18784728
Vet Clin Pathol. 2015 Jun;44(2):287-94
pubmed: 25688652
Pharmacol Ther. 2021 Feb;218:107668
pubmed: 32853629
Cancer Lett. 2007 Dec 18;258(2):155-64
pubmed: 17977647
Nature. 2003 Oct 23;425(6960):821-4
pubmed: 14574408
Transl Oncol. 2016 Feb;9(1):79-88
pubmed: 26947885
Hum Pathol. 1980 Sep;11(5 Suppl):535-9
pubmed: 6253386
NPJ Precis Oncol. 2022 Jan 27;6(1):9
pubmed: 35087207
ACS Biomater Sci Eng. 2020 Jul 13;6(7):4314-4323
pubmed: 33463347
Am J Clin Pathol. 1980 Jan;73(1):31-5
pubmed: 6243441
Cancer Cell. 2022 Feb 14;40(2):168-184.e13
pubmed: 35120600
J Vis Exp. 2020 Mar 25;(157):
pubmed: 32281982
Life Sci. 2020 May 15;249:117483
pubmed: 32135187
Front Mol Biosci. 2021 Jun 21;8:672518
pubmed: 34235178
Acta Cytol. 1986 Jan-Feb;30(1):21-4
pubmed: 3004078
Int J Mol Sci. 2020 Dec 14;21(24):
pubmed: 33327663
Cancer Cell Int. 2021 Jan 20;21(1):62
pubmed: 33472628
Cell Res. 2014 Nov;24(11):1299-310
pubmed: 25342560
Int J Mol Sci. 2022 Oct 21;23(20):
pubmed: 36293537
Biochem Soc Trans. 2019 Apr 30;47(2):725-732
pubmed: 30850425
Anticancer Res. 2013 Sep;33(9):3715-23
pubmed: 24023301
Cancer Lett. 2021 Apr 1;502:133-142
pubmed: 33444690
J Oncol. 2022 Nov 26;2022:5277440
pubmed: 36471888
Mol Cell Oncol. 2015 Jan 23;2(4):e1002707
pubmed: 27308493
Oral Oncol. 2012 Feb;48(2):e4-6
pubmed: 21940197
BMC Cancer. 2020 Sep 3;20(1):843
pubmed: 32883229
Science. 1988 Apr 8;240(4849):177-84
pubmed: 2451290
Proteomics. 2018 Mar;18(5-6):e1700167
pubmed: 29280568
Oncotarget. 2017 Dec 5;9(1):249-267
pubmed: 29416611
J Clin Diagn Res. 2016 Sep;10(9):ZE18-ZE21
pubmed: 27790599
Cell. 2007 Nov 30;131(5):966-79
pubmed: 18045538
Mol Reprod Dev. 2021 Apr;88(4):287-301
pubmed: 33734523
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
J Cutan Pathol. 1999 Nov;26(10):533-6
pubmed: 10599947
J R Soc Interface. 2016 Oct;13(123):
pubmed: 27733696
Nat Nanotechnol. 2010 Apr;5(4):291-6
pubmed: 20228788
Int J Oncol. 2021 Jun;58(6):
pubmed: 33887877
Nat Rev Cancer. 2010 Jan;10(1):9-22
pubmed: 20029421
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6447-E6456
pubmed: 27698134
PLoS One. 2015 Jul 24;10(7):e0133895
pubmed: 26208323
Vet Med Sci. 2023 Jul;9(4):1833-1847
pubmed: 37196179
J Oral Biol Craniofac Res. 2021 Apr-Jun;11(2):125-131
pubmed: 33532199
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Oncogenesis. 2018 Jan 24;7(1):10
pubmed: 29362402
Exp Oncol. 2015 Dec;37(4):242-5
pubmed: 26710834
Cancers (Basel). 2020 Jun 29;12(7):
pubmed: 32610529
Life Sci. 2021 Dec 1;286:120028
pubmed: 34627776
J Oral Pathol Med. 2014 Jul;43(6):454-8
pubmed: 24450575
Histopathology. 1979 Nov;3(6):467-88
pubmed: 229072
Science. 2006 Sep 15;313(5793):1642-5
pubmed: 16902090
Int J Oral Sci. 2021 Mar 25;13(1):12
pubmed: 33762576
Cells. 2020 Mar 06;9(3):
pubmed: 32155738
Nature. 2021 May;593(7858):282-288
pubmed: 33828302
BMC Mol Cell Biol. 2020 Nov 7;21(1):79
pubmed: 33160318
Front Oncol. 2020 Oct 15;10:541878
pubmed: 33178577
J Transl Med. 2013 Aug 27;11:198
pubmed: 23981300
J Transl Med. 2021 Dec 20;19(1):513
pubmed: 34930321
Oncol Rep. 2011 Apr;25(4):1013-20
pubmed: 21271223
SLAS Technol. 2019 Aug;24(4):420-428
pubmed: 31225974
Cell Death Dis. 2021 Jun 18;12(7):629
pubmed: 34145217
Diagn Cytopathol. 2011 Mar;39(3):229-33
pubmed: 21319327
Front Cell Dev Biol. 2019 Jan 29;7:4
pubmed: 30761299
Trends Mol Med. 2004 Jun;10(6):249-50
pubmed: 15177187
Cells. 2021 Mar 10;10(3):
pubmed: 33801903
Toxics. 2022 Jul 24;10(8):
pubmed: 35893848
Cancers (Basel). 2022 Jan 12;14(2):
pubmed: 35053529

Auteurs

Leonardo de Oliveira Siquara da Rocha (LO)

Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil.
Department of Pathology and Forensic Medicine, School of Medicine, Federal University of Bahia, Salvador 40110-100, BA, Brazil.

Bruno Solano de Freitas Souza (BSF)

Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil.
D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.

Ricardo Della Coletta (RD)

Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba 13414-903, SP, Brazil.
Graduate Program in Oral Biology, School of Dentistry, University of Campinas, Piracicaba 13414-903, SP, Brazil.
ORCID: 0000-0001-5285-3046

Daniel W Lambert (DW)

School of Clinical Dentistry, The University of Sheffield, Sheffield S10 2TA, UK.
ORCID: 0000-0001-9003-3145

Clarissa A Gurgel Rocha (CA)

Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador 40296-710, BA, Brazil.
Department of Pathology and Forensic Medicine, School of Medicine, Federal University of Bahia, Salvador 40110-100, BA, Brazil.
D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.
Department of Propaedeutics, School of Dentistry, Federal University of Bahia, Salvador 40110-150, BA, Brazil.
ORCID: 0000-0001-8922-2985

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Carcinome épidermoïde de la tête et du cou › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs épidermoïdes › Carcinome épidermoïde › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Maladies du système stomatognathique › Maladies de la bouche › Tumeurs de la bouche › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Mapping Cell-in-Cell Structures in Oral...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › Mapping Cell-in-Cell Structures in Oral...